Summary
- Current Price
- As of today, HELP price is $11.45, down -0.35% on
- Current Price All-Time High
- HELP price is currently -91.09% below its historical high of $128.44 set on
- Market Cap
- HELP current market cap is $710M, up +329.75% over the past 365 days
- Revenue
- HELP current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for HELP has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Cybin D/B/A Helus Pharma |
| Ticker | NASDAQ: HELP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | cybin.com |
| Employees | 50 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $11.45 | |
| Price, 1D Change | -0.35% | |
| $710M | ||
| - | ||
| - | ||
| 2.22 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.25 | ||
| EPS, 1Y Change | -5.73% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | CYBN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$4.25 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $11.45 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$2.89 | - | |
| - | -$4.02 | - | |
| - | -$4.25 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $11.45 | |
| $6.28 | ||
| $6.82 | ||
| $6.56 | ||
| $7.59 | ||
| $1.25 | ||
| 2.22 | ||
| $0.75 | ||
| 71.57 | ||
| 142.23% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$4.25 | ||
| -$120.00K | ||
| - | ||
| -$142.59M | ||
| - | ||
| -$148.00M | ||
| - | ||
| -$142.47M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 9.52 | ||
| 9.52 | ||
| - | ||
| - | ||
| 18.72 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 3.06 | ||
| -3.88 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $231.79M | ||
| $157.26M | ||
| $251.17M | ||
| $184.52M | ||
| $19.38M | ||
| $19.38M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Expenses
| Metric | Value | Date |
|---|---|---|
| $148.00M | ||
| $142.47M | ||
| $120.00K | ||
| $0.00 | ||
| $120.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$133.27M | ||
| -$1.36M | ||
| $198.24M | ||
| $1.37M | ||
| -$134.64M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | ||
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| TD Cowen | ||
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with HELP
FAQ
- What is the ticker symbol for Cybin D/B/A Helus Pharma?
- The ticker symbol for Cybin D/B/A Helus Pharma is NASDAQ:HELP
- Does Cybin D/B/A Helus Pharma pay dividends?
- No, Cybin D/B/A Helus Pharma does not pay dividends
- What sector is Cybin D/B/A Helus Pharma in?
- Cybin D/B/A Helus Pharma is in the Healthcare sector
- What industry is Cybin D/B/A Helus Pharma in?
- Cybin D/B/A Helus Pharma is in the Biotechnology industry
- What country is Cybin D/B/A Helus Pharma based in?
- Cybin D/B/A Helus Pharma is headquartered in Canada
- When did Cybin D/B/A Helus Pharma go public?
- Cybin D/B/A Helus Pharma initial public offering (IPO) was on September 13, 2019
- Is Cybin D/B/A Helus Pharma in the S&P 500?
- No, Cybin D/B/A Helus Pharma is not included in the S&P 500 index
- Is Cybin D/B/A Helus Pharma in the NASDAQ 100?
- No, Cybin D/B/A Helus Pharma is not included in the NASDAQ 100 index
- Is Cybin D/B/A Helus Pharma in the Dow Jones?
- No, Cybin D/B/A Helus Pharma is not included in the Dow Jones index
- When was Cybin D/B/A Helus Pharma last earnings report?
- Cybin D/B/A Helus Pharma's most recent earnings report was on August 11, 2026
- When does Cybin D/B/A Helus Pharma report earnings?
- The date for Cybin D/B/A Helus Pharma's next earnings report has not been announced yet
Data Sources & References
- HELP Official Website cybin.com
- HELP Profile on Yahoo Finance finance.yahoo.com/quote/HELP
- HELP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/help